Highlights
- The blood test, also called liquid biopsy diagnoses skin cancer more efficiently than other methods.
- The test is said to be a revolutionary one as it identifies melanoma which could only be detected by surgery, previously.
This new blood test is called a liquid biopsy, because it can often replace the need for a much slower, and often invasive, surgical biopsy. From a blood sample, researchers can identify whether a melanoma patient will respond to a specific treatment, and also learn when a treatment stops working and new treatment options need to be explored.
The test will be made available at Melbourne's Olivia Newton-John Cancer Research Institute (ONJCRI), Victoria state's Health Minister Jill Hennessy.
Prior to the development of the new test, melanomas could only be identified by a complex and invasive surgery, results from which could take weeks to be obtained.
"We're putting cancer patients first and investing in world-leading cancer research and future technologies that have the power to save lives," Hennessy told reporters in Melbourne.